Accelerating Science Feature
Frontiers in immuno-oncology and personalized medicine
Unlock the potential of the immune system in the fight against cancer with advancements in immuno-oncology and precision medicine.
Explore the latest therapeutic developments using groundbreaking discoveries such as immune checkpoint inhibitors, CAR-T cell therapy, adoptive cell transfer, neoantigen targeting, and more. Hear from experts researching the role of tumor-infiltrating lymphocytes (TILs), natural killer (NK) cells, and monoclonal antibodies (mAbs) in enhancing immune response, and see how these insights are helping to develop personalized immunotherapies and revolutionize cancer treatment.
Multiomic profiling of colorectal cancer reveals interactions between antigen-presenting CAFs & T cells
Discover spatial multiomic profiling of colorectal cancer using Miltenyi’s MICS technology. Four distinct cancer-associated fibroblasts subpopulations were identified, including a novel immunosuppressive TinCAF population that interacts with immune cells. These insights into the tumor microenvironment offer new opportunities for biomarker discovery and immunotherapy targets.
Download resource
Decode the TME for biomarker discovery and immunotherapy insights
See how advanced technologies from Raybiotech help unlock critical insights into tumor biology by addressing key areas such as biomarker discovery, tumor-immune interactions, personalized immunotherapy, and data integration.
Watch webinar
Expert panel: Current and future trends in liquid biopsies for early cancer detection
Early cancer detection remains one of the biggest challenges in oncology, with many cancers going undetected until later stages when treatment options are more limited. Advances in multi-cancer early detection (MCED) aim to address this by identifying multiple cancer types through a single test, often using a simple blood draw. Join our expert panel discussion exploring the future of early detection and the science behind better liquid biopsies.
Register for free
How antibody-drug conjugates are advancing cancer treatment
Gain insight into what makes ADCs a game-changer in oncology, the key manufacturing challenges, and what the future may hold for this evolving therapeutic approach.
Watch video series
Accelerate neoantigen-based immunotherapy development for cancer treatment
With this free eBook, learn how to overcome challenges in neoantigen-based immunotherapy development and leverage synthetic peptides for cancer treatment.
Download eBook
Unraveling the tumor microenvironment of pancreatic cancer
Dr. Julienne Carstens highlights the critical role of spatial biology in understanding the metastatic progression of PDAC and advancing personalized immunotherapy.
Read article
Explore the rest of our Accelerating Cancer Research feature
